Member Type: Diagnostic Companies

Inivata, a global clinical cancer genomics company, employs the precision of circulating tumor DNA (ctDNA) analysis to improve personalized health care. Inivata’s expertise, cutting-edge technology and advanced bioinformatics analysis can detect and characterize cancer-related mutations and enable non-invasive testing at multiple points along the cancer care cycle. Using a simple blood test, Inivata’s proprietary technology provides oncologists with clinically actionable information to guide therapy selection, monitor treatment and detect resistance mutations as they emerge.

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today

Download a Member List